StonvexLoading…
StonvexStonvexStonvexCore line items from MRKR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $751.69K | $3.55M | $2.44M | $1.21M |
Operating Income | $-4.07M | $-12.89M | $-11.01M | $-8.87M |
Net Income | $-3.18M | $-12.16M | $-10.46M | $-8.46M |
EPS (Diluted) | $-0.16 | $-0.79 | $-0.75 | $-0.67 |
Total Assets | $17.43M | $19.07M | $21.73M | $14.77M |
Total Liabilities | $3.64M | $2.27M | $3.35M | $4.28M |
Cash & Equivalents | $14.92M | $16.07M | $17.59M | $10.46M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 16.70M | 16.70M | 16.70M | 11.30M |